Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis

By Kozak T.   Havrdova E.   Pit'ha J.   Gregora E.   Pytlk R.   Maaloufova J.   Kobylka P.   Vodvarkova S.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2179-2181

Elsevier

Access to resources Recommend Favorite

Drug resistance gene transfer - Stem cell protection and therapeutic efficacy

By Gerson S.L.  

Experimental Hematology, Vol. 28, Iss. 12, 2000-12 ,pp. : 1315-1324

Elsevier

Access to resources Recommend Favorite

Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies

By Helbig Grzegorz   Stella-Holowiecka Beata   Wojnar Jerzy   Krawczyk Malgorzata   Krzemien Slawomira   Wojciechowska-Sadus Maria   Markiewicz Mirosław   Wylezol Iwona   Kopera Malgorzata   Holowiecki Jerzy  

Annals of Hematology, Vol. 86, Iss. 9, 2007-09 ,pp. : 677-683

Springer Publishing Company

Access to resources Recommend Favorite

Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: An Open Label Study

By  

Current Stem Cell Research & Therapy, Vol. 7, Iss. 6, 2012-11 ,pp. : 407-414

Bentham Science Publishers

Access to resources Recommend Favorite

Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis

By Nasa Giorgio   Littera Roberto   Cocco Eleonora   Battistini Luca   Marrosu Maria   Contu Licinio  

Annals of Hematology, Vol. 83, Iss. 6, 2004-06 ,pp. : 403-405

Springer Publishing Company

Access to resources Recommend Favorite